Descriptor English: | Cytochrome P-450 CYP2C8 | ||||
Descriptor Spanish: |
Citocromo P-450 CYP2C8
| ||||
Descriptor Portuguese: | Citocromo P-450 CYP2C8 | ||||
Descriptor French: | Cytochrome P-450 CYP2C8 | ||||
Entry term(s): |
4-Hydroxylase, S-Mephenytoin CYP2C8 CYP2C8, Cytochrome P-450 CYPIIC8 Cytochrome P 450 CYP2C8 Cytochrome P450 MP 20 Cytochrome P450 MP-20 Cytochrome P450, Family 2, Subfamily C, Polypeptide 8 P-450 CYP2C8, Cytochrome P450 MP-20, Cytochrome S Mephenytoin 4 Hydroxylase S-Mephenytoin 4-Hydroxylase |
||||
Tree number(s): |
D08.244.453.005.590 D08.244.453.491.368 D08.811.682.690.708.170.010.590 D08.811.682.690.708.170.450.360 D12.776.422.220.453.010.590 D12.776.422.220.453.491.360 |
||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D065727 | ||||
Scope note: | A liver microsomal cytochrome P450 hydroxylase that oxidizes a broad spectrum of substrates including STEROIDS, FATTY ACIDS, and XENOBIOTICS. Examples of pharmaceutical substrates for CYP2C8 include; PACLITAXOL; torsemide; and; AMODIAQUINE |
||||
Allowable Qualifiers: |
AD administration & dosage AE adverse effects AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DE drug effects DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||
Entry Combination: |
antagonists & inhibitors:Cytochrome P-450 CYP2C8 Inhibitors
|
||||
Registry Number: | EC 1.14.14.1 | ||||
Previous Indexing: |
Aryl Hydrocarbon Hydroxylases (2002-2014) |
||||
Public MeSH Note: | 2015 |
||||
History Note: | 2015 |
||||
DeCS ID: | 55607 | ||||
Unique ID: | D065727 | ||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||
Date Established: | 2015/01/01 | ||||
Date of Entry: | 2014/06/26 | ||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Enzymes and Coenzymes [D08]Enzymes and Coenzymes -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Cytochrome P-450 CYP2C8
- Preferred
Concept UI |
M0590595 |
Scope note | A liver microsomal cytochrome P450 hydroxylase that oxidizes a broad spectrum of substrates including STEROIDS, FATTY ACIDS, and XENOBIOTICS. Examples of pharmaceutical substrates for CYP2C8 include; PACLITAXOL; torsemide; and; AMODIAQUINE |
Preferred term | Cytochrome P-450 CYP2C8 |
Entry term(s) |
4-Hydroxylase, S-Mephenytoin CYP2C8 CYP2C8, Cytochrome P-450 CYPIIC8 Cytochrome P 450 CYP2C8 Cytochrome P450 MP 20 Cytochrome P450 MP-20 Cytochrome P450, Family 2, Subfamily C, Polypeptide 8 P-450 CYP2C8, Cytochrome P450 MP-20, Cytochrome S Mephenytoin 4 Hydroxylase S-Mephenytoin 4-Hydroxylase |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey